1-Methyl-7-methoxy-1,8-naphthyridin-2-on | 49655-94-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 1-Methyl-7-methoxy-1,8-naphthyridin-2-on
• 英文别名: 7-methoxy-1-methyl-1H-[1,8]naphthyridin-2-one；7-Methoxy-1-methyl-1,8-naphthyridin-2(1H)-one；7-methoxy-1-methyl-1,8-naphthyridin-2-one
• CAS: 49655-94-9
• 化学式: C₁₀H₁₀N₂O₂
• 分子量: 190.202
• InChiKey: NSWVYPKCELOMKY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  42.4
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] HETEROCYCLIC COMPOUNDS, IN PARTICULAR 2-OXO-4,4,5,5,6,6,7,7-OCTAHYDROBENZOXAZOLE DERIVATIVES, AND THEIR USE AS ANTIBACTERIAL COMPOUNDS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES, EN PARTICULIER DÉRIVÉS DE 2-OXO -4,4,5,5,6,6,7,7-OCTAHYDROBENZOXAZOLE, ET LEUR UTILISATION EN TANT QUE COMPOSÉS ANTIBACTÉRIENS
  申请人：REDX PHARMA PLC

  公开号：WO2017137744A1

  公开（公告）日：2017-08-17

  This invention relates to antibacterial drug compounds containing a bicyclic core, typically a bicycle in which one of the rings is an oxazolidinone. It also relates to pharmaceutical formulations of antibacterial drug compounds. It also relates to uses of the compounds in treating bacterial infections and in methods of treating bacterial infections.

  这项发明涉及含有双环核心的抗菌药物化合物，通常是其中一个环是噁唑烷酮的双环。它还涉及抗菌药物化合物的药物配方。它还涉及化合物在治疗细菌感染和治疗细菌感染方法中的用途。
• [EN] ANTIBACTERIAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIBACTÉRIENS
  申请人：REDX PHARMA PLC

  公开号：WO2017137743A1

  公开（公告）日：2017-08-17

  This invention relates to antibacterial drug compounds containing a bicyclic core, typically a bicycle in which one of the rings is an oxazolidinone. It also relates to pharmaceutical formulations of antibacterial drug compounds. It also relates to uses of the derivatives in treating bacterial infections and in methods of treating bacterial infections.

  该发明涉及含有双环核心的抗菌药物化合物，通常是其中一个环为噁唑烷酮的双环。它还涉及抗菌药物化合物的药物配方。它还涉及衍生物在治疗细菌感染和治疗细菌感染方法中的用途。
• Compounds for use in antibacterial applications
  申请人：GlaxoSmithKline Intellectual Property Development Limited

  公开号：US10364254B2

  公开（公告）日：2019-07-30

  The present invention relates to novel compounds or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions and treatment methods or uses as antibacterials for bacterial infections.

  本发明涉及作为细菌感染抗菌剂的新型化合物或其药学上可接受的盐、相应的药物组合物和治疗方法或用途。
• Antibacterial compounds
  申请人：AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A.

  公开号：US10633366B2

  公开（公告）日：2020-04-28

  The present invention relates to novel antibacterial compounds (1) as defined below, pharmaceutical compositions containing them and their use as antimicrobials. A compound of formula (1): A-L1-Y-L2-R—B, wherein A is a cyclic group having one of the following formulae (I), (II) and (III), and wherein B is cyclic group having one of the following formulae (IV) to (IX).

  本发明涉及如下定义的新型抗菌化合物(1)、含有它们的药物组合物及其作为抗菌剂的用途。式（1）化合物：A-L1-Y-L2-R-B，其中 A 是具有下式(I)、(II)和(III)之一的环状基团，B 是具有下式(IV)至(IX)之一的环状基团。
• COMPOUNDS FOR US IN ANTIBACTERIAL APPLICATIONS
  申请人：GlaxoSmithKline Intelledtual Property Development Limited

  公开号：US20190031680A1

  公开（公告）日：2019-01-31

  The present invention relates to novel compounds or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions and treatment methods or uses as antibacterials for bacterial infections.